Table 2.

Association between SOX13 expression and clinicopathologic features.

Characteristics	N	SOX13 expression, n (%)		P
		Low	High
Age(y)				0.797
≥50	90	52	38
<50	77	46	31
T stage				0.421
Tis	4	1	3
T1	67	43	24
T2	85	48	37
T3	10	5	5
T4	1	1	0
N stage				0.046
N0	101	62	39
N1	40	25	15
N2	15	9	6
N3	11	2	9
TNM stage				0.082
0	4	1	3
I	43	27	16
II	91	58	33
III	29	12	17
IV	0	0	69
ER status				0.051
Negative	56	27	29
Positive	111	71	40
PR status				0.141
Negative	64	33	31
Positive	103	65	38
HER-2 status				0.802
Negative	134	78	56
Positive	33	20	13
Molecular classification				0.016
Luminal A	36	25	11
Luminal B	70	43	27
HER2-E	29	19	10
TNBC	32	11	21